Medscape InDiscussion: Respiratory Syncytial Virus in Adults
Medscape
- 12
- Episodes
- 2023
- First episode
About Medscape InDiscussion: Respiratory Syncytial Virus in Adults
Listen to Medscape InDiscussion: Respiratory Syncytial Virus in Adults, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985977). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
- Publisher
- Medscape
- Category
- health & fitness · science
- Language
- en
- Explicit
- No
- First episode
- 10 May 2023
- Latest episode
- 4 Jun 2024
Latest episodes
12 episodes in the feed.
4 Jun 2024
S2 Episode 6: When RSV Hits Home: Community Care in Rural West Virginia
Join Drs Forest Arnold and Brittanie West as they discuss their personal experience preventing and managing RSV in adults in their Appalachian communities. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998284. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview RSV in Rural Communities: Lessons From Appalachia https://www.medscape.com/viewarticle/985982 CDC RSV Surveillance and Research https://www.cdc.gov/rsv/research/index.html American Hospital Association Rural Report rural-report-2019.pdf (aha.org) https://www.aha.org/system/files/2019-02/rural-report-2019.pdf Physician Learning Preferences physician-learning-report-2022.pdf (doximity.com) https://press.doximity.com/reports/physician-learning-report-2022.pdf Do You Spend More Time Searching for Medical Information Than the Average American? https://swnsdigital.com/us/2020/11/do-you-spend-more-time-searching-for-medical-information-than-the-average-american/ One Assay to Test Them All: Multiplex Assays for Expansion of Respiratory Virus Surveillance https://pubmed.ncbi.nlm.nih.gov/37168265/ Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index.html RSVVaxView https://www.cdc.gov/vaccines/imz-managers/coverage/rsvvaxview/index.html REVIRAL 1 https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/reviral-1/ A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein https://pubmed.ncbi.nlm.nih.gov/31712214/
2 May 2024
S2 Episode 5: Epidemiology of RSV: Accurate Diagnosis, Treatment Options, and Risk Factors
Join Drs Forest Arnold and Angela R. Branche as they discuss the epidemiology of RSV, the importance of an accurate diagnosis, treatment options, cohorting, and risk factors. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998283. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 https://www.cdc.gov/mmwr/volumes/72/wr/mm7214a1.htm Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/35873302/ Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test https://pubmed.ncbi.nlm.nih.gov/33298613/ Comparative Analysis of Three Multiplex Platforms for the Detection of Respiratory Viral Pathogens https://pubmed.ncbi.nlm.nih.gov/36099751/ Centers for Disease Control and Prevention: Respiratory Syncytial Virus (RSV) https://www.cdc.gov/rsv/index.html
3 Apr 2024
S2 Episode 4: RSV and Healthcare Facilities: Preventing Outbreaks and Minimizing Transmission With Education, Testing, and Cohorting
Join Drs Forest Arnold and Hannah Nam as they discuss preventing RSV outbreaks within healthcare facilities, and strategies to minimize RSV transmission among healthcare workers and patients. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998282). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index.html CDC – Respiratory Syncytial Virus (RSV) Vaccination Coverage and Intent for Vaccination, Adults 60 Years and Older, United States https://www.cdc.gov/vaccines/imz-managers/coverage/rsvvaxview/adults-60-coverage-intent.html CDC - Healthcare Providers: RSV Vaccination for Adults 60 Years of Age and Over https://www.cdc.gov/vaccines/vpd/rsv/hcp/older-adults.html Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted (Rx) – Arexvy https://reference.medscape.com/drug/arexvy-respiratory-syncytial-virus-rsv-vaccine-adjuvanted-4000359 Respiratory Syncytial Virus (RSV) Vaccine (Rx) – Abrysvo https://reference.medscape.com/drug/abrysvo-respiratory-syncytial-virus-rsv-vaccine-4000347
5 Mar 2024
S2 Episode 3: Long-Term Outcomes of Severe RSV Infection in Adults
Join Drs Forest Arnold and Christopher Robinson as they discuss long-term outcomes of severe RSV infection in adults. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998281). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Neurologic Manifestations of Severe Respiratory Viral Contagions https://pubmed.ncbi.nlm.nih.gov/32426749/ Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) https://emedicine.medscape.com/article/235980-overview Excitotoxicity: Still Hammering the Ischemic Brain in 2020 https://pubmed.ncbi.nlm.nih.gov/33192266/ Clinical Manifestations and Pathogenesis of Acute Necrotizing Encephalopathy: The Interface Between Systemic Infection and Neurologic Injury https://pubmed.ncbi.nlm.nih.gov/35058867/ Acute Disseminated Encephalomyelitis https://www.ncbi.nlm.nih.gov/books/NBK430934/ Mild Encephalopathy With Reversible Splenial Lesion: Description of Nine Cases and Review of the Literature https://pubmed.ncbi.nlm.nih.gov/33839562/ Respiratory Syncytial Virus Infects Peripheral and Spinal Nerves and Induces Chemokine-Mediated Neuropathy https://pubmed.ncbi.nlm.nih.gov/38135285/ Selective Serotonin Reuptake Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK554406/
1 Feb 2024
S2 Episode 2: RSV and Traveler Health
Join Drs Forest Arnold and Lin Chen as they discuss RSV and traveler health. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998279). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample https://pubmed.ncbi.nlm.nih.gov/35968878/ Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018 https://pubmed.ncbi.nlm.nih.gov/35226079/ Estimated Incidence of Respiratory Hospitalizations Attributable to RSV Infections Across Age and Socioeconomic Groups https://pubmed.ncbi.nlm.nih.gov/36280891/ The Annual Economic Burden of Respiratory Syncytial Virus in Adults in the United States https://pubmed.ncbi.nlm.nih.gov/38060972/ Almost 200 People Reported COVID-19 After Attending CDC Conference https://www.idse.net/Covid-19/Article/05-23/COVID-COVID-19-CDC-Conference-Outbreak/70425 CDC Traveler's Health Branch https://www.cdc.gov/ncezid/dgmq/focus-areas/travelers-health.html Traveler-Based Genomic Surveillance for Early Detection of New SARS-CoV-2 Variants https://wwwnc.cdc.gov/travel/page/travel-genomic-surveillance CDC Expands Testing of International Air Traveler Samples to Include Flu, RSV, and Other Respiratory Viruses https://www.cdc.gov/media/releases/2023/s1107-testing-respiratory-viruses.html GeoSentinel https://geosentinel.org/ Travellers and Influenza: Risks and Prevention https://pubmed.ncbi.nlm.nih.gov/28077609/
1 Feb 2024
S2 Episode 1: Risk Factors and Complications of RSV in Adults
Join Drs Forest Arnold and Edward Walsh as they discuss risk factors and complications of RSV in adults. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998278). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources RSV Surveillance & Research https://www.cdc.gov/rsv/research/index.html Respiratory Viral Infections in the Elderly https://pubmed.ncbi.nlm.nih.gov/33749408/ Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins https://pubmed.ncbi.nlm.nih.gov/24362685/ Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus https://pubmed.ncbi.nlm.nih.gov/24179220/ Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines https://pubmed.ncbi.nlm.nih.gov/37887775/ Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults https://pubmed.ncbi.nlm.nih.gov/37018468/ Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults https://pubmed.ncbi.nlm.nih.gov/38091530/ Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults https://pubmed.ncbi.nlm.nih.gov/36791160/ Vaccine Adverse Event Reporting System https://vaers.hhs.gov/reportevent.html RSV ACIP Vaccine Recommendations https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/rsv.html
7 Sept 2023
S1 Episode 6: RSV in Rural Communities: Lessons From Appalachia
Rates of RSV are rising in rural communities. How are rural healthcare providers responding? Join Drs Forest Arnold and Brittanie West as they discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985982). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Hemoglobin A1c Testing https://emedicine.medscape.com/article/2049478-overview The Utility of Point of Care Ultrasonography (POCUS) https://pubmed.ncbi.nlm.nih.gov/34840746/ Bedside Lung Ultrasound in Emergency Protocol as a Diagnostic Tool in Patients of Acute Respiratory Distress Presenting to Emergency Department https://pubmed.ncbi.nlm.nih.gov/29937643/ Noncardiogenic Pulmonary Edema Imaging https://emedicine.medscape.com/article/360932-overview Procalcitonin (PCT) https://emedicine.medscape.com/article/2096589-overview RSV-associated Hospitalization Surveillance Network https://www.cdc.gov/rsv/research/rsv-net/dashboard.html Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus https://pubmed.ncbi.nlm.nih.gov/35107357/ State-level Estimates of COPD https://www.cdc.gov/copd/data-and-statistics/state-estimates.html ACIP Recommendations https://www.cdc.gov/vaccines/acip/recommendations.html CDC Recommends a Powerful New Tool to Protect Infants From the Leading Cause of Hospitalization https://www.cdc.gov/media/releases/2023/p-0803-new-tool-prevent-infant-hospitalization-.html Evidence to Recommendations for Nirsevimab https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-02/slides-02-23/rsv-pediatric-04-jones-508.pdf
9 Aug 2023
S1 Episode 5: 50+ Years in the Making, RSV Vaccine Arrives
Dr Barney Graham, Time's 2021 Hero of the Year for his work on the COVID-19 vaccine, joins Dr Forest Arnold in this episode covering the groundbreaking work done to develop an RSV vaccine. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985981). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Field Evaluation of a Respiratory Syncytial Virus Vaccine and a Trivalent Parainfluenza Virus Vaccine in a Pediatric Population https://pubmed.ncbi.nlm.nih.gov/4305200/ Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins https://pubmed.ncbi.nlm.nih.gov/24362685/ Identification and Characteristics of Fusion Peptides Derived From Enveloped Viruses https://pubmed.ncbi.nlm.nih.gov/34497798/ Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease https://pubmed.ncbi.nlm.nih.gov/26677198/ Structure-based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus https://pubmed.ncbi.nlm.nih.gov/24179220/ FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine Vaccine-associated Enhanced Disease: Case Definition and Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data https://pubmed.ncbi.nlm.nih.gov/33637387/ Th1 and Th2 Responses: What Are They? https://pubmed.ncbi.nlm.nih.gov/10938051/ Cytokine Pathways in Allergic Disease https://pubmed.ncbi.nlm.nih.gov/22301949/
12 Jul 2023
S1 Episode 4: Breakthrough: RSV Therapies in the Pipeline
Treatment therapies for adults with RSV have been elusive, but there are promising breakthroughs on the horizon. Join Drs Forest Arnold and Richard Plemper as they discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985980). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Cell Entry of Enveloped Viruses https://pubmed.ncbi.nlm.nih.gov/21927634/ Product Review on the Monoclonal Antibody Palivizumab for Prevention of Respiratory Syncytial Virus Infection https://pubmed.ncbi.nlm.nih.gov/28605249/ Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Children https://pubmed.ncbi.nlm.nih.gov/34783356/ Nirsevimab: A Promising Therapy for RSV https://pubmed.ncbi.nlm.nih.gov/35544094/ Nirsevimab for Prevention of RSV in Healthy Late-preterm and Term Infants https://pubmed.ncbi.nlm.nih.gov/35235726/ Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study https://pubmed.ncbi.nlm.nih.gov/25140957/ A Phase 2b, Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Lower Respiratory Tract https://pubmed.ncbi.nlm.nih.gov/31915807/ Ark Biopharmaceutical Presents Positive Results in Phase 3 AIRFLO Study of Ziresovir in RSV-infected Hospitalized Infants at 12th International RSV Symposium https://www.globenewswire.com/en/news-release/2022/10/07/2530040/0/en/Ark-Biopharmaceutical-Presents-Positive-Results-in-Phase-3-AIRFLO-Study-of-Ziresovir-in-RSV-Infected-Hospitalized-Infants-at-12th-International-RSV-Symposium.html Structural Insight Into Paramyxovirus and Pneumovirus Entry Inhibition https://pubmed.ncbi.nlm.nih.gov/32245118/ Molnupiravir for Treatment of COVID-19 https://pubmed.ncbi.nlm.nih.gov/35134041/ NIH COVID-19 Treatment Guidelines—Molnupiravir https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/molnupiravir/ Quantitative Efficacy Paradigms of the Influenza Clinical Drug Candidate EIDD-2801 in the Ferret Model https://pubmed.ncbi.nlm.nih.gov/31945316/ Compound Summary Molnupiravir https://pubchem.ncbi.nlm.nih.gov/compound/Molnupiravir
14 Jun 2023
S1 Episode 3: RSV Infections in Patients Receiving Bone Marrow Transplant
RSV infection before or after bone marrow transplantation or CAR T-cell therapy can be challenging to manage. Tune in to hear experts Drs Forest Arnold and Melody Smith discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985979). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Hematopoietic Stem Cell Transplantation (HSCT) https://emedicine.medscape.com/article/208954-overview Cancer Immunotherapy With Chimeric Antigen Receptor (CAR) T Cells https://emedicine.medscape.com/article/2500108-overview Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index.html Diagnosis of Respiratory Syncytial Virus Infection: Comparison of Reverse Transcription-PCR to Viral Culture and Serology in Adults With Respiratory Illness https://pubmed.ncbi.nlm.nih.gov/11880399/ Conditioning Regimen https://www.cancer.gov/publications/dictionaries/cancer-terms/def/conditioning-regimen Ribavirin (Rx) https://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625 FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine Graft Versus Host Disease (GVHD) https://emedicine.medscape.com/article/429037-overview Infections After Hematopoietic Stem Cell Transplantation https://emedicine.medscape.com/article/1013470-overview#a5
10 May 2023
S1 Episode 2: How to Manage RSV in Long-Term Care Facilities
Join Drs Forest Arnold and Laura Morton as they discuss the diagnosis and treatment of RSV in older adults living in long-term care facilities and congregational living spaces. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985978). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Ribavirin (Rx) https://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625 The Immune System in the Elderly: A Fair Fight Against Diseases? https://www.medscape.com/viewarticle/780507_2 Gov. Beshear: Long-Term Care Task Force Working to Protect Kentuckians https://www.kentucky.gov/Pages/Activity-stream.aspx?n=GovernorBeshear&prId=133 RSV in Older Adults and Adults With Chronic Medical Conditions https://www.cdc.gov/rsv/high-risk/older-adults.html The Flutter https://www.physio-pedia.com/Flutter Incentive Spirometry https://www.physio-pedia.com/Incentive_Spirometry Advance Care Planning: Advance Directives for Healthcare https://www.nia.nih.gov/health/advance-care-planning-advance-directives-health-care
10 May 2023
S1 Episode 1: RSV Trends After COVID-19: Back With a Vengeance
Join Drs Forest Arnold and Victoria Statler as they discuss RSV after the COVID-19 pandemic. Tune in to hear about an increase in hospitalization rates, surprising seasonal shifts, and more. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985977). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources CDC RSV National Trends https://www.cdc.gov/surveillance/nrevss/rsv/natl-trend.html RSV-NET https://www.cdc.gov/rsv/research/rsv-net/overview-methods.html Palivizumab for the Prevention of Respiratory Syncytial Virus Infection https://pubmed.ncbi.nlm.nih.gov/20705882/ Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins https://pubmed.ncbi.nlm.nih.gov/24362685/ Updated Guidance: Use of Palivizumab Prophylaxis to Prevent Hospitalization From Severe Respiratory Syncytial Virus Infection During the 2022-2023 RSV Season https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/interim-guidance-for-use-of-palivizumab-prophylaxis-to-prevent-hospitalization/ Type and Duration of Precautions Recommended for Selected Infections and Conditions https://www.cdc.gov/infectioncontrol/guidelines/isolation/appendix/type-duration-precautions.html
Host of Medscape InDiscussion: Respiratory Syncytial Virus in Adults?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.